Increasing accumulation of the beta-amyloid peptides (Aβ) in the brain, a pathological phenomenon termed progressive amyloidopathy, is thought to be an important factor underlying the decline of cognitive functions in Alzheimer’s disease (AD) (Selkoe and Hardy, 2016). Here, APP is linked to Alzheimer disease.